FOLH1 and posterior cortical atrophy: 18F-PSMA-1007 skeletal uptakewithout substrate on low-dose CT (non-specific) could lead to an increase indisagreement between observers and, subsequently, could make clinical decision morecomplicated.10,11 The lack of data focusing specifically on this subjecthighlights the urgent need to investigate the impact of skeletal (non-specific)18F-PSMA-1007 uptake in PCa patients.